BELLANTI, FRANCESCO
 Distribuzione geografica
Continente #
NA - Nord America 6.576
EU - Europa 6.548
AS - Asia 4.183
Continente sconosciuto - Info sul continente non disponibili 680
SA - Sud America 521
AF - Africa 69
OC - Oceania 7
Totale 18.584
Nazione #
US - Stati Uniti d'America 6.440
SG - Singapore 1.463
CN - Cina 1.408
IT - Italia 1.389
IE - Irlanda 1.356
RU - Federazione Russa 831
UA - Ucraina 812
SE - Svezia 730
BR - Brasile 436
HK - Hong Kong 388
FR - Francia 377
DE - Germania 349
FI - Finlandia 237
IN - India 233
VN - Vietnam 223
TR - Turchia 174
GB - Regno Unito 147
AT - Austria 78
CA - Canada 67
BD - Bangladesh 66
NL - Olanda 42
MX - Messico 39
ES - Italia 35
BE - Belgio 33
PL - Polonia 33
AR - Argentina 30
CZ - Repubblica Ceca 28
JP - Giappone 28
IQ - Iraq 27
ID - Indonesia 26
ZA - Sudafrica 25
EU - Europa 18
PK - Pakistan 18
AE - Emirati Arabi Uniti 17
SA - Arabia Saudita 15
CH - Svizzera 13
CO - Colombia 11
IR - Iran 11
KR - Corea 11
VE - Venezuela 11
CL - Cile 10
EC - Ecuador 10
LT - Lituania 10
UZ - Uzbekistan 10
JO - Giordania 9
KE - Kenya 9
AL - Albania 8
PH - Filippine 8
TN - Tunisia 8
EG - Egitto 7
KZ - Kazakistan 7
RO - Romania 7
HN - Honduras 6
IL - Israele 6
JM - Giamaica 6
MA - Marocco 6
HU - Ungheria 5
MY - Malesia 5
PY - Paraguay 5
RS - Serbia 5
AU - Australia 4
AZ - Azerbaigian 4
DZ - Algeria 4
LV - Lettonia 4
TH - Thailandia 4
BO - Bolivia 3
CR - Costa Rica 3
GR - Grecia 3
NI - Nicaragua 3
NP - Nepal 3
NZ - Nuova Zelanda 3
PA - Panama 3
PE - Perù 3
PS - Palestinian Territory 3
TT - Trinidad e Tobago 3
BG - Bulgaria 2
CI - Costa d'Avorio 2
DK - Danimarca 2
GE - Georgia 2
GT - Guatemala 2
KG - Kirghizistan 2
LB - Libano 2
MM - Myanmar 2
MT - Malta 2
SI - Slovenia 2
SN - Senegal 2
SY - Repubblica araba siriana 2
TW - Taiwan 2
UY - Uruguay 2
XK - ???statistics.table.value.countryCode.XK??? 2
A1 - Anonimo 1
A2 - ???statistics.table.value.countryCode.A2??? 1
BA - Bosnia-Erzegovina 1
BB - Barbados 1
BH - Bahrain 1
BS - Bahamas 1
BY - Bielorussia 1
CM - Camerun 1
GA - Gabon 1
KW - Kuwait 1
Totale 17.912
Città #
Dublin 1.356
San Jose 1.248
Singapore 734
Chandler 648
Jacksonville 555
Nyköping 482
Ashburn 401
Hong Kong 381
Dearborn 342
Beijing 316
Dallas 269
Nanjing 238
Santa Clara 227
Council Bluffs 182
Lauterbourg 157
Wilmington 152
New York 146
Princeton 133
Nanchang 114
Columbus 111
Moscow 108
Rome 107
Helsinki 105
Munich 105
San Mateo 95
Ho Chi Minh City 92
Ann Arbor 91
The Dalles 89
Boardman 73
Vienna 72
Milan 69
Bari 66
Shenyang 64
Foggia 57
Woodbridge 55
Tianjin 53
Los Angeles 51
Kunming 46
São Paulo 46
Hebei 41
Turku 41
Hanoi 38
Jiaxing 36
Des Moines 34
Brussels 33
Changsha 32
Hangzhou 32
Frankfurt am Main 31
Jinan 30
Houston 28
Toronto 28
Stevenage 27
Shanghai 26
Delhi 24
Naples 24
Redwood City 24
London 23
Seattle 23
Tokyo 23
Zhengzhou 23
Ningbo 22
Brno 20
Guangzhou 20
Florence 19
Hilden 19
Warsaw 18
Pune 17
Rio de Janeiro 17
San Francisco 17
Assago 16
Norwalk 16
Palermo 16
Brooklyn 15
Bologna 14
Chennai 14
Chicago 14
Jakarta 14
Orem 14
Atlanta 13
Caserta 13
Mola Di Bari 13
Wuhan 13
Belo Horizonte 12
Fuzhou 12
Hillsboro 12
Montreal 12
Baghdad 11
Barcelona 11
Haiphong 11
Paris 11
Phoenix 11
San Severo 11
Turin 11
Charlotte 10
Johannesburg 10
Kraków 10
Orange 10
Padova 10
Taizhou 10
Augusta 9
Totale 10.805
Nome #
Effetti della sarcopenia e dell’obesità sarcopenica sul rischio cardiovascolare 851
Effetti dell’associazione tra malnutrizione e sarcopenia sulla composizione corporea 283
A silybin-phospholipid vitamin E complex (siliphos) limits the hepatic damage and reduces oxidative stress in human obesity – related liver disease. 209
A silybin-phospholipid-vitamin E complex (SILIPHOS) prevents oxidation of UCP2 and limits mitochondrial dysfunction during non-alcoholic steatohepatitis. 202
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 201
Liver toxicity induced by amiodarone is dependent on mitochondria Complex I impairment, OXPHOS uncoupling and cardiolipin peroxidation. 183
Effetti del diabete mellito tipo 2 sulla composizione corporea dei pazienti sarcopenici 177
Alteration of fatty acid beta-oxidation observed in severe steatosis depends on CPT1 impairment and change in mitochondrial membrane lipid composition. 168
Aging e disaccoppiamento mitocondriale: diverso effetto sulla produzione di radicali liberi in tessuti mitotici e post-mitotici. 167
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 165
DAAs rapidly reduce inflammation but increase serum VEGF level: A rationale for tumor risk during anti-HCV treatment 164
Adherence to Mediterranean Diet, Malnutrition, Length of Stay and Mortality in Elderly Patients Hospitalized in Internal Medicine Wards 163
A silybin-phospholipid complex prevents mitochondrial dysfunction in a rodent model of nonalcoholic steatohepatitis 159
Alterations of Clock Gene RNA Expression in Brain Regions of a Triple Transgenic Model of Alzheimer’s Disease 155
Meccanismi del danno ed effetti protettivi di exenatide in un modello sperimentale di ischemia/riperfusione cerebrale 155
A Silybin-phospholipid Complex Prevents Mitochondrial Oxidative Stress in Models of Chronic Liver Disease. 154
Alterations of hepatic ATP homeostasis and respiratory chain during development of non-alcoholic steatohepatitis in a rodent model 153
UCP2 overexpression sensitizes NASH liver to ischemia/reperfusion injury by increasing mitochondrial proton leak. 152
Uncoupling protein-2 (UCP2) induces mitochondrial proton leak and increases susceptibility of non-alcoholic steatohepatitis (NASH) liver to ischaemia-reperfusion injury 151
Il complesso silibina-fosfolipidi-vitamina E normalizza l’ipertransaminasemia in soggetti affetti da steatosi epatica non alcolica. 150
A silybin-phospholipids-vitamin E complex (siliphos) reduces oxidative stress in patients affected by non-alcoholic hepatic steatosis. 148
Disaccoppiamento mitocondriale in corso di Steatoepatite Non Alcolica 147
Oxidative stress is increased in sarcopenia and associated with cardiovascular disease risk in sarcopenic obesity (Q1 WoS) 145
DAAs increase serum VEGF level: a rationale for tumour risk recurrence during anti-HCV treatment 145
N-acetylcysteine prevents amiodarone-induced inhibition of Complex I, OXPHOS uncoupling and cardiolipin peroxidation in rat liver mitochondria. 142
A silybin-phospholipid-vitamin E complex reduces mitochondrial oxidative stress in a rodent model of chronic cholestasis. 141
Diagnostic reliability of the procalcitonin serum marker in septic frail patient 141
Analisi della bioenergetica mitocondriale in corso di Ischemia/Riperfusione renale e ruolo protettivo del postcondizionamento ischemico. 139
Alterazioni bioenergetiche mitocondriali durante lo sviluppo della Steatoepatite Non Alcolica 136
Principles and therapeutic relevance for targeting mitochondria in aging and neurodegenerative diseases. 136
Bioenergetics in aging: mitochondrial proton leak in aging rat liver, kidney and heart 135
UCP2 increase the sensibilità to liver ischemia/reperfusion injury in a NASH model. 134
Mitochondria peroxide synthesis and CPT-1 nitrosylation durino NASH development: a model of oxidative stress disease 133
Oxidative stress and aging. 133
Amiodarone induces liver toxicity by impairing liver mitochondria bioenergetics and redox balance. 133
Exenatide e gli inibitori di DPP-4 sono efficaci nel trattamento della neuropatia sensitiva associata a diabete mellito tipo II in pazienti anziani 132
Oxidation of Carnitine Palmitoyl Transferase 1 alters fatty acid metabolism in a rodent model of nonalcoholic steatohepatitis. 131
CPT-1 is a key target of mitochondria nitrosylation during NASH development 131
UCP2 induces mitochondrial uncoupling during nonalcoholic steatohepatitis: An adaptative mechanism to reduce oxidative stress but producing depletion of ATP 131
Transarterial chemoembolization vs bland embolization in hepatocellular carcinoma: A meta-analysis of randomized trials 131
THE ROLE OF TRANSIENT ELASTOGRAPHY (FIBROSCAN) IN THE STUDY OF LIVER FIBROSIS IN SSc 130
Effects of dietary fatty acids and cholesterol excess on liver injury: a lipidomic approach 130
A myoferlin gain-of-function variant associates with a new type of hereditary angioedema 130
Alterazioni della bioenergetica mitocondriale in un modello animale di ipoperfusione cerebrale cronica. 129
Mitochondrial Oxidative Stress is an Early Event in Amiodarone Hepatotoxicity, Inducing Complex I Impairment and Cardiolipin Peroxidation. 128
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 128
Ultramicronized palmitoylethanolamide rescues learning and memory impairments in a triple transgenic mouse model of Alzheimer's disease by exerting anti-inflammatory and neuroprotective effects 128
Lo stress ossidativo e la disfunzione mitocondriale nella NASH causano l’attivazione del PTP inducendo l’apoptosi. 126
Oxidation of Hepatic Carnitine Palmitoyl Transferase-I (CPT-I) Impairs Fatty Acid Beta-Oxidation in Rats Fed a Methionine-Choline Deficient Diet. 126
MITOCHONDRIAL DYSFUNCTIONS IN A TRANSGENIC MURINE MODEL OF ALZHEIMER’S DISEASE 126
Disfunzione mitocondriale in differenti aree cerebrali in un modello transgenico di Alzheimer. 126
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 125
Polimorfismi del gene della Glutatione S-Trasferasi Omega -1: analisi del linkage disequilibrium fra i polimorfismi Ala140Asp E Glu155ΔGlu dell’esone 4 e interazione con l’ApoE in una popolazione di centenari pugliesi 125
Il postcondizionamento renale protegge il rene dal danno da ischemia riperfusione attraverso l’inibizione del mitchondrial permeabilità transitino pore. 124
Combined Effects of 2 Interleukin 28B Polymorphisms on the Therapeutic Outcome of Hepatitis C Patients with Circulating Cryoglobulins 123
UCP2 increase the sensibility to liver ischemia/reperfusion injury in a NASH model. 122
Cerebral oligoemia induces mitochondria dysfunction and increase in hydroperoxide production in a chronic rat model of vascular dementia. 121
Efficacy and safety of direct-acting antivirals in elderly with chronic hepatitis C: results from a retrospective cohort study 120
Nella steatoepatite indotta da amiodarone le alterazioni della funzione mitocondriale precedono la steatosi e la necrosi e suggeriscono nuove strategie di intervento terapeutico. 116
Propofol but not sevoflurane prevents mitochondrial dysfunction and oxidative stress by limiting HIF-1α activation in hepatic ischemia/reperfusion injury (Q1 WoS) 116
Mitochondrial Signaling and Hepatocellular Carcinoma: Molecular Mechanisms and Therapeutic Implications 116
Glutamatergic alterations and mitochondrial impairment in a murine model of Alzheimer disease 116
Studio delle alterazioni comportamentali e istologiche in un modello animale di oligoemia cerebrale cronica. 114
Reactive Oxygen Species (ROS) and liver disease therapy 114
Rat brain bioenergetics is impaired in a two-vessel occlusion model of vascular dementia. 112
Oxidative stress and mitochondrial dysfunction are associated with the opening of permeability transition pore in a rodent model of NAFLD. 112
Oxysterols induce mitochondrial impairment and hepatocellular toxicity in non-alcoholic fatty liver disease 112
Changes in circulating redox bilance and increased markers of oxidative stress predict Frailty condition: the “Oxidative Frailty Syndrome”. 111
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell'assessment bioenergetico. 110
Comparison of Three Nutritional Screening Tools with the New Glim Criteria for Malnutrition and Association with Sarcopenia in Hospitalized Older Patients 110
Oxysterols in the orchestra of liver cell metabolism 109
A Novel Nutraceuticals Mixture Improves Liver Steatosis by Preventing Oxidative Stress and Mitochondrial Dysfunction in a NAFLD Model 109
Mitochondrial activity in NASH pathogenesis: role of respiratory chain and fatty acids transport 108
Lipid oxidation products in the pathogenesis of non-alcoholic steatohepatitis 108
NASH induces expression of UCP2 and mitochondria respiratory impairment in liver hepatocytes 107
Molecular Aspects and Treatment of Iron Deficiency in the Elderly 107
Malnutrition in Hospitalized Old Patients: Screening and Diagnosis, Clinical Outcomes, and Management 107
Mitochondrial involvement in non-alcoholic steatohepatitis 106
Direct-acting antivirals restore systemic redox homeostasis in chronic HCV patients (Q1 WoS) 106
Inhibition of nuclear factor (erythroid-derived 2)-like 2 promotes hepatic progenitor cell activation and differentiation (Q1 WoS) 106
Mitochondrial proton leak during aging: ditferent effect on free radicals production in mitotic and postmitotic tissues. 104
An Amino Acid Mixture to Counteract Skeletal Muscle Atrophy: Impact on Mitochondrial Bioenergetics (Q1 WoS) 103
Disfunzione mitocondriale in differenti aree cerebrali di ratti senescenti: importanza dell’assessment bioenergetico. 101
Blood Magnesium Level and Selected Oxidative Stress Indices in Lead-Exposed Workers 101
Treatment of chronic HCV infection in the era of protease inhibitors 100
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-REPERFUSION INJURY 100
PROPOFOL, BUT NOT SEVORANE, PROTECTS MITOCHONDRIA AND LIVER FUNCTION AFTER ISCHEMIA-RIPERFUSION INJURY 100
Changes in circulating redox balance and increased markers of oxidative stress predict Frailty condition: the "Oxidative Frailty Syndrome'' 100
Effect of sevoflurane and propofol anaesthesia on mitochondria and postoperative hepatocellular injury in steatotic patients: preliminary data: 9AP5‐7 97
HNE induces UCP2 expression and proton leak to limit oxidative stress but reduces ATP synthesis in non-alcoholic steatohepatitis. 96
Renal postconditioning: a novel mechanism in the prevention of I/R damage. 96
Frailty syndrome is associated with altered circulating redox balance and increased markers of oxidative stress 95
Mitochondrial oxidative stress and respiratory chain dysfunction account for liver toxicity during amiodarone but not dronedarone administration. 95
Free radical biology for medicine: learning from nonalcoholic fatty liver disease. 94
An open-label, single-center pilot study to test the effects of an amino acid mixture in older patients admitted to internal medicine wards 91
La supplementazione di silibina e vitamina E (silyphos) previene la disfunzione mitocondriale osservata nella steatoepatite non alcolica. 91
Mitochondrial dysfunction in nonalcoholic steatohepatitis. 90
Fatal relapse of COVID-19 after recovery? A case report of an older Italian patient 90
Reliability of serum procalcitonin concentration for the diagnosis of sepsis in elderly patient with chronic kidney disease 89
Prognostic factors for anastomotic urinary leakage following retropubic radical prostatectomy and correlation with voiding outcomes 89
Totale 13.527
Categoria #
all - tutte 94.600
article - articoli 0
book - libri 0
conference - conferenze 0
curatela - curatele 0
other - altro 0
patent - brevetti 0
selected - selezionate 0
volume - volumi 0
Totale 94.600


Totale Lug Ago Sett Ott Nov Dic Gen Feb Mar Apr Mag Giu
2021/2022911 0 12 23 16 98 40 51 110 123 102 83 253
2022/20233.270 331 171 151 157 176 280 40 265 1.501 35 65 98
2023/2024807 96 44 38 47 47 213 29 43 13 18 56 163
2024/20252.874 161 76 122 134 128 348 286 133 680 184 303 319
2025/20265.301 351 354 575 621 346 236 1.168 606 299 409 146 190
2026/2027451 119 332 0 0 0 0 0 0 0 0 0 0
Totale 18.584